PROTEOLUTIONS
LIVE

Serial Number

79433858

Owner

Proteolutions UG (haftungsbeschränkt)

Attorney

Ralph Locher

Filing Date

Jun 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PROTEOLUTIONS Trademark

Serial Number: 79433858

PROTEOLUTIONS is a trademark filed by Proteolutions UG (haftungsbeschränkt) on June 11, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Proteolutions UG (haftungsbeschränkt)

Rudower Chaussee 17

Entity Type: 99

Trademark Details

Filing Date

June 11, 2025

Registration Date

Not Registered

Goods & Services

Scientific and technological services, namely, scientific research, analysis and development in the field of codon-optimized DNA sequences for protein expression, binding proteins and protein-based agents, providing codon-optimized DNA sequence information for protein expression and product research and design relating thereto; DNA screening and optimization for scientific research purposes, all of the above for use in industry, especially, the creation of codon-optimized DNA sequences for protein expression and the creation of codon-optimized DNA sequences for universal protein expression in a variety of production organisms; computer aided design services, in relation to binding proteins, protein-based agents; consultancy and information in relation to the aforesaid services, included in this class.

Biological preparations for use in industry and science; nucleic recombinant acids, other than for medical use or veterinary purposes; Nucleic acid sequences, namely, codon-optimized DNA sequences for protein expression, other than for medical use or veterinary purposes; Nucleic acid sequences, namely, codon-optimized DNA sequences for universal protein expression in a variety of production organisms, other than for medical use or veterinary purposes; Protein in raw material form for scientific and medical research and protein for industrial use, namely, recombinant proteins, protein sequences, for use in industry, science, in particular, in silico designed binding proteins; Nucleic acids, other than for medical or veterinary purposes, namely, nucleic acid sequencing programs.

Recorded content, namely, recorded computer programs for codon optimization of DNA sequences for protein expression and in silico design of binding proteins and protein agents, and electronic data and databases recorded on computer media in the field of codon optimized DNA sequences for protein expression; downloadable software for codon optimization of DNA sequences for protein expression and in silico design of binding proteins and protein agents, including downloadable application software, system and system support software and firmware, web applications and server software, artificial intelligence software and machine learning software; computer interfaces and recorded application programming interface (API) software for the automated codon optimization of DNA sequences for protein expression and in silico design of binding proteins and protein agents.

Medical and veterinary preparations, namely, biological and biochemical reagents for medical or veterinary purposes, and diagnostic agents, preparations and substances for medical and veterinary purposes; nucleic recombinant acids and nucleic recombinant sequences, for medical use; biological and biochemical reagents for medical or veterinary purposes, namely, recombinant proteins and protein sequences, for medical use, especially, in silico designed protein agents; biological and biochemical reagents for medical or veterinary purposes, namely, codon-optimized DNA sequences for protein expression, for medical use.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 1, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2026 TROA
REFUSAL PROCESSED BY IB
Jan 1, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 17, 2025 RFCS
REFUSAL PROCESSED BY MPU
Dec 17, 2025 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 5, 2025 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 6, 2025 RFCR
NON-FINAL ACTION WRITTEN
Nov 5, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 3, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 3, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 2, 2025 REPR